Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Arroyo (Cincinnati, United States of America), M. Echaide (Madrid, Spain), E. Batllori (Madrid, Spain), A. Galindo (Madrid, Spain), F. Moreno-Herrero (Madrid, Spain), J. Pérez-Gil (Madrid, Spain), P. Kingma (Cincinnati, United States of America). Characterization of the activity of the different oligomeric forms of pulmonary human surfactant protein SP-D. 2382

Member's Comments

No comment yet.

Related content which might interest you: Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 Ultrastructure of the pulmonary surfactant and its alterations after general inhibition of protein synthesis in the rat Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002 A novel non-BRICHOS surfactant protein C mutation causing infantile interstitial lung disease is associated with reduced mature SP-C level Source: International Congress 2018 – Orphan diseases in children Year: 2018 Effects of Cys85 on biochemical properties and biological function of human SP-A variants Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity Year: 2007 Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar proteinosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Visualization of apoptosis-related proteins in lung treated with recombinant human active protein C in sepsis model Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005 FK506-binding protein 11, a novel plasma cell specific antibody folding catalyst, is increased in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Characterisation of TNF-alpha lectin-like domain derived peptides associated with improved alveolar fluid clearance in pulmonary oedema Source: Annual Congress 2011 - Translational models of airway disease Year: 2011 Influence of recombinant human vascular endothelium growth factor- (rhVEGF-) 165 on surfactant proteins (SPs) mRNA levels in emphysematous rat lungs Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 LSC - 2019 - Surfactant protein SP-D to the rescue of NETosis and NET-induced lung surfactant inactivation Source: International Congress 2019 – Injury and repair: less is more Year: 2019 Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011 Characterisation of eppin function: expression and activity in the lung Source: Eur Respir J, 50 (1) 1601937; 10.1183/13993003.01937-2016 Year: 2017 Anti-rhinoviral activity of soluble ICAM-1/FC fusion protein in primary airway epithelial cells from COPD patients Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Evaluation of alveolar surfactant aggregates in vitro and in vivo Source: Eur Respir J 2002; 19: 41-46 Year: 2002 Kinetics of extracellular matrix proteins and TGF-β in a rat lung model of elastase induced emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 197s Year: 2001 Effect of surfactant phospholipids on human eosinophils Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations Source: Annual Congress 2009 - Genetics of lung diseases Year: 2009 How does smoking influence major phospholipids and proteins in lung surfactant? Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant Source: Eur Respir J, 59 (1) 2100267; 10.1183/13993003.00267-2021 Year: 2022 Change in serum surfactant protein (SP)-A, SP-D and KL-6 predict the therapeutic effect of antifibrotic drugs in IPF. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019